Acumen Pharmaceuticals, Inc. ABOS 深 滬
交易中 05-06 12:13:01 美东时间
2.61
+0.090
+3.57%
華盛通- 最 高2.615
- 今 開2.54
- 成交量 7.56万股
- 最 低 2.515
- 昨 收 2.52
- 總市值 18.85万
- 52周最高 3.60
- 市盈率 靜 --
- 換手率 0.10%
- 52周最低 0.9901
- 委 比 35.94%
- 總股本 7.22万
- 歷史最高 26.98
- 量 比 0.79
- 振 幅 3.97%
- 歷史最低 0.8551
- 每 手 1
- 風險率 0.63%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Acumen Pharmaceuticals shares are trading lower after the company reported a year-over-year decrease in Q4 EPS results.
Acumen Pharmaceuticals shares are trading lower after the company reported a ye...
03-27 21:29
美股大行评级 | 大摩、高盛上调Denali Therapeutics目标价；Chewy、沛齐遭多家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Atossa Therapeutics"买入"评级，目标价从7美元升至25美元；Needham：维持Nkarta"买入"评级，目标价从10美元升至11美元
03-27 10:22
BTIG Reiterates Buy on Acumen Pharmaceuticals, Maintains $8 Price Target
BTIG analyst Thomas Shrader reiterates Acumen Pharmaceuticals (NASDAQ:ABOS) with a Buy and maintains $8 price target.
03-27 00:32
Acumen Pharmaceuticals Q4 EPS $(0.41) Beats $(0.43) Estimate
Acumen Pharmaceuticals (NASDAQ:ABOS) reported quarterly losses of $(0.41) per share which beat the analyst consensus estimate of $(0.43) by 5.09 percent. This is a 33.87 percent increase over losses of $(0.62) per share
03-26 20:23
Earnings Scheduled For March 26, 2026
Companies Reporting Before The Bell • ProShares UltraShort Russell2000 (NYSE:TW...
03-26 19:11
Acumen Pharmaceuticals shares are trading higher after the company announced a $35.75 million equity private placement at $3.30 per share.
Acumen Pharmaceuticals shares are trading higher after the company announced a ...
03-16 20:47
Market-Moving News for March 16th
NBIS: 17% | Nebius Announced 5-Year $12B AI Infrastructure Agreement With Meta To Provide Dedicated Capacity Across Multiple Locations Using NVIDIA Vera Rubin Platform Starting Early 2027 CTMX: 70%
03-16 19:30
Acumen Pharmaceuticals Announces Private Placement Of ~$35.75M At $3.30/Share
Proceeds from the financing are expected to primarily support Acumen's Enhanced Brain Delivery (EBD) program, including ongoing preclinical development work to support the nomination of a lead clinical candidate
03-16 18:36
Acumen Shares New Alzheimer's Drug Data At Global Brain Disease Conference
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer's disease (AD),
03-03 21:04
美股牛股 | 机器人公司 RR飙升逾44%，公司与微软携手开发AI机器人技术；Redwire大涨近30%
机器人公司RR飙升逾44%，与微软携手开发AI机器人技术；Redwire大涨近30%，获巨额国防合同，最高可达1510亿美元；SATL大涨20%，出售卫星布局澳洲市场>>
01-28 19:42
